Scientific Advisory Board

Harry Greenberg, M.D.

Chairman

Dr. Greenberg is currently the Joseph D. Grant Professor of Medicine and Microbiology and Immunology and the Senior Associate Dean for Research and Training at Stanford University School of Medicine. He was formerly Sr. Vice President and Chief Scientific officer at Aviron. He is a virologist and a world leader in enteric diseases as well as one of the inventors of bovine rotavirus vaccineTM. He is an expert in vaccine safety and efficacy serving as a member of the CDC’s Advisory Committee on Immunization Practices (ACIP) and as chairman of FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC). He has published over 350 scientific papers, served on the editorial boards of a number of journals, and is currently an editor of the Journal of Virology. Dr. Greenberg is a member or fellow of a variety of scholarly societies including the ASCI, AAP, ASV and the AAAS. Dr. Greenberg received his M.D. from Columbia College of Physicians and Surgeons in 1970.


John S. Patton, Ph.D.

Dr. Patton was Co-Founder and Chief Scientific Officer, Nektar Therapeutics. He is a renowned expert in the pulmonary delivery of peptides and proteins. Before co-founding Inhale Therapeutic Systems, he led the drug delivery group at Genentech, where he demonstrated the feasibility of systemic delivery of large molecules through the lungs. Prior to joining Genentech, Dr. Patton was a tenured professor at the University of Georgia. Dr. Patton received his Ph.D. in biology from the University of California, San Diego, and held post-doctoral positions in biomedicine at Harvard Medical School and the University of Lund in Sweden.


Jerry Pier, Ph.D.

Dr. Pier is Professor of Medicine, Microbiology and Molecular Genetics Brigham and Women’s Hospital, Harvard Medical School. He is a molecular microbiologist and a recognized expert on Pseudomonas and Staphylococci. He is the inventor of human anti-Pseudomonas aeruginosa monoclonal antibodies (Aerucin™) and a number of vaccines and antibody therapeutics against Pseudomonas and Staphylococci. He has published over 150 publications on pathogen: host interactions, bacterial virulence factors, cystic fibrosis, and treatment for Pseudomonas infections. Dr. Pier is also the senior editor of a major new immunology textbook entitled Immunology, Infection and Immunity.


Arnold Smith, M.D.

Dr. Smith is Professor Pediatrics in the Department of Pathobiology, University of Washington and a Member of the Seattle Biomedical Research Institute. He spent over 15 years developing better antibiotic treatment for children with cystic fibrosis at Children's Hospital and Regional Medical Center in Seattle. He performed the first clinical trials demonstrating efficacy of inhaled tobramycin against CF lung infections. A pediatric infectious disease expert, Dr. Smith spent the first two decades of his academic career at Harvard Medical School then at University of Missouri School of Medicine as part of teams that developed a vaccine to prevent life-threatening Haemophilus influenzae infections. He was Professor and Chair, Department of Molecular Microbiology and Immunology at University of Missouri Medical School and Acting Chief of the Division of Infectious Diseases of the Children’s Hospital Medical Center at Harvard Medical School.

Scientific Advisory Board

Aridis Pharmaceuticals  © 2009-2013 Le3 Web Designs

Site Map  |  Privacy Policy


|  Financial Conflict of Interest Policy